Brief: Immunovia Q3 Pretax Loss Narrows To SEK 36.1 Mln
Nov 11 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* Q3 NET SALES SEK 377,000 VERSUS SEK 37,000 YEAR AGO
* Q3 PRETAX LOSS SEK 36.1 MILLION VERSUS LOSS SEK 38.1
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrbjMG39
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study